Given their role in cancer, targeting ROS has emerged as a potential therapeutic strategy. One approach is to increase ROS levels beyond a tolerable threshold, inducing selective cancer cell death. Agents such as pro-oxidants and drugs that inhibit antioxidant defenses are being investigated for this purpose.
